Mr David Lydon > McCann FitzGerald LLP > Dublin, Ireland > Lawyer Profile

McCann FitzGerald LLP has a strong reputation for handling contentious, regulatory, and transactional mandates for a broad spectrum of clients, including telecoms regulators, fixed line and mobile network operators, OTT providers, broadcasters, cable TV operators, and telecoms infrastructure companies. Rosaleen Byrne, Amy Brick, and Catherine Derrig head the contentious telecoms practice and regularly represent clients in proceedings before the Commercial Court. David Lydon and Garreth O’Brien are well-known for providing administrative and corporate law advice to domestic and international telecom clients. Laura Treacy is active in the telecoms regulatory landscape and advises on regulatory aspects of telecoms transactions, covering licensing, interconnection, spectrum allocation, and infrastructure access.

McCann FitzGerald LLP continues to handle a high volume of transactional work, including private equity investments. Real estate, engineering, life sciences, insurance, aviation, energy and pharmaceuticals are key sector strengths for the corporate and M&A team, which is equally adept at advising financial institutions on deals. Stephen FitzSimons heads the corporate practice, and David Byers and David Lydon are highly regarded practitioners in the market. Ben Gaffikin, Garreth O’Brien, Alan Fuller and Valerie Lawlor have excellent reputations in the space. Brendan Murphy, Gill Lohan, Stephen Fuller and John Neeson are emerging talents. Aidan Lawlor and Conor O’Dwyer have left the firm.

McCann FitzGerald LLP has a major presence in contentious, transactional and regulatory aspects of life sciences and healthcare. It continues to be noted for product liability and has acted for clients in many of the largest cases in recent Irish history. IP and commercial disputes are also a forte for the team, which has an established record in transactions and regulatory matters. Fiona O’Beirne is hugely experienced in IP and commercial disputes, notably patent litigation in the medical device and pharmaceutical sectors; she and her team continue to act for clients in a range of headline cases. Roddy Bourke is a market leader in product liability cases and corporate partner David Lydon has a background in high-value life sciences transactions.